Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 12 of 12 for “"GLP-1R agonists"”.

  1. Ingestive Effects of GLP-1R Agonists in the VTA

    Glucagon-like peptide-1 (GLP-1) deceases blood sugar levels with only a low risk of hypoglycemia. This has made the GLP-1 system a useful target for the treatment of type 2 diabetes mellitus. Further investigation of the effects of GLP-1 receptor (GLP-1R) analogs has shown that GLP-1 also plays a …

    buffalo Repository record for Ingestive Effects of GLP-1R Agonists in the VTA (opens in a new tab)

  2. BEHAVIORAL AND CIRCUIT-LEVEL INSIGHTS INTO GLP-1 RECEPTOR AGONIST-MEDIATED REDUCTION OF DRUG SEEKING

    … and overdose. Glucagon-like peptide-1 receptor (GLP-1R) agonists have emerged as a promising class of therapeutics for treating substance use disorders. Notably, these compounds reduce opioid seeking without directly engaging the MOR. However, the neural mechanisms mediating this effect remain …

    penn Repository record for BEHAVIORAL AND CIRCUIT-LEVEL INSIGHTS INTO GLP-1 RECEPTOR AGONIST-MEDIATED REDUCTION OF DRUG SEEKING (opens in a new tab) Embargoed until 2029-01-29

  3. Repurposing diabetes drugs for the treatment of intestinal helminth infection

    … peptide hormone, glucagon-like peptide-1(GLP-1). However, how these GLP-1 receptor (GLP-1r)+ IELs respond during infection is completely unknown. We used the mouse model of whipworm Trichuris muris to investigate whether already clinically approved GLP-1r agonist treatment could influence …

    lancaster Download PDF for Repurposing diabetes drugs for the treatment of intestinal helminth infection (opens in a new tab)

  4. Human physiology of intra-cranial pressure and the biological role of GLP-1 agonists

    … data demonstrates the ability of Exenatide, a GLP-1R agonist, to reduce CSF secretion and intracranial pressure (ICP) in an in vivo model. Existing GLP-1R agonists are widely used to treat obesity and diabetes (but do not cause hypoglycaemia). In the IIH Pressure trial 16 female participants …

    birmingham Download PDF for Human physiology of intra-cranial pressure and the biological role of GLP-1 agonists (opens in a new tab)

  5. Συστηματική ανασκόπηση και μετα-ανάλυση της αποτελεσματικότητας και της ασφάλειας των αγωνιστών του υποδοχέα του γλυκαγονόμορφου πεπτιδίου-1 (GLP-1R) στην απώλεια βάρους και σε μεταβολικές παραμέτρους σε γυναίκες με σύνδρομο πολυκυστικών ωοθηκών (ΣΠΟ) / Systematic review and meta-analysis of the efficacy and safety of glucagon-like peptide 1 receptor (GLP-1R) agonists for weight Loss and metabolic parameters in females with Polycystic Ovary Syndrome (PCOS)

    … του υποδοχέα του γλυκαγονόμορφου πεπτιδίου-1 (GLP-1 receptor agonists) έχουν προσελκύσει ιδιαίτερο ενδιαφέρον λόγω της ικανότητάς τους να προκαλούν απώλεια σωματικού βάρους και να βελτιώνουν μεταβολικές παραμέτρους. Σκοπός της παρούσας εργασίας ήταν η συστηματική ανασκόπηση και μετα-ανάλυση της …

    athens Repository record for Συστηματική ανασκόπηση και μετα-ανάλυση της αποτελεσματικότητας και της ασφάλειας των αγωνιστών του υποδοχέα του γλυκαγονόμορφου πεπτιδίου-1 (GLP-1R) στην απώλεια βάρους και σε μεταβολικές παραμέτρους σε γυναίκες με σύνδρομο πολυκυστικών ωοθηκών (ΣΠΟ) / Systematic review and meta-analysis of the efficacy and safety of glucagon-like peptide 1 receptor (GLP-1R) agonists for weight Loss and metabolic parameters in females with Polycystic Ovary Syndrome (PCOS) (opens in a new tab)

  6. Liraglutide-stimulated cardioprotection: Is it novel and can it be an anti-anginal agent?

    Introduction <br/>Glucagon-like peptide-1 (GLP-1) is an incretin hormone essential for normal human glucose homeostasis. Expression of the GLP-1 receptor (GLP-1R) in the myocardium has fuelled growing interest in the direct and indirect cardiovascular effects of native GLP-1, its degradation …

    kings Repository record for Liraglutide-stimulated cardioprotection: Is it novel and can it be an anti-anginal agent? (opens in a new tab) Download PDF for Liraglutide-stimulated cardioprotection: Is it novel and can it be an anti-anginal agent? (opens in a new tab)

  7. Glucagon-like peptide-1 influences proliferation within the spinal cord; an effect via cerebrospinal fluid contacting neurons?

    The influence of glucagon-like peptide-1 (GLP-1) on CNS functions, such as neurogenesis, neuroprotection, and anti-neuroinflammation, prompted investigation into its role in spinal neurogenesis. Ependymal cells (ECs) in the vicinity of the central canal, possess neural stem cell-like …

    whiterose Download PDF for Glucagon-like peptide-1 influences proliferation within the spinal cord; an effect via cerebrospinal fluid contacting neurons? (opens in a new tab)

  8. Investigating the Molecular and Physiological Roles of Glucagon like peptide-1, Scavenger receptor class B type 1 and the Gut Microbiota in Modulating Intestinal Chylomicron Production

    … and rodent studies have shown that the use of GLP-1R agonists leads to a reduction in chylomicron production. Furthermore, recent findings indicated that the gut microbiota and their metabolites play a significant role in the onset of diabetic dyslipidemia. Considering the principles of …

    toronto-retro Repository record for Investigating the Molecular and Physiological Roles of Glucagon like peptide-1, Scavenger receptor class B type 1 and the Gut Microbiota in Modulating Intestinal Chylomicron Production (opens in a new tab)

  9. CENTRAL GLP-1 SYSTEM AND ESTROUS CYCLE REGULATION OF INGESTIVE BEHAVIOR

    … peptide, glucagon-like peptide-1 (GLP-1). However, preclinical investigations characterizing the neural mechanisms through which the GLP-1 system and FDA-approved GLP-1 receptor (GLP-1R) agonists (GLP-1RAs) reduce food intake largely occurred in males. To this end, the present …

    penn Repository record for CENTRAL GLP-1 SYSTEM AND ESTROUS CYCLE REGULATION OF INGESTIVE BEHAVIOR (opens in a new tab)

  10. Mitochondrial Bioenergetics and Supercomplexes in Heart Failure: Mechanisms and Therapeutic Approaches

    … induced by glucagon-like peptide-1 receptor (GLP-1R) agonists. Using a high-fat high-cholesterol diet model combined with a myocardial infarction (MI) model, we evaluated the impact of the GLP-1R agonist, semaglutide, in mediating changes in cardiac function, myocardial metabolic remodeling, …

    ottawa-retro Repository record for Mitochondrial Bioenergetics and Supercomplexes in Heart Failure: Mechanisms and Therapeutic Approaches (opens in a new tab)

  11. Characterising the expression and function of islet G protein-coupled receptor regulatory proteins

    … in the presence or absence of selected GPCR agonists; and (4) Investigate the effects of Rgs2 downregulation on β cell function using siRNA Rgs2 knock-down (KD) and wild-type control MIN6 cells.<br/><br/><i>GRK2/3</i> mRNAs were predominantly expressed in mouse and human islets and they were …

    kings Repository record for Characterising the expression and function of islet G protein-coupled receptor regulatory proteins (opens in a new tab) Download PDF for Characterising the expression and function of islet G protein-coupled receptor regulatory proteins (opens in a new tab)